The expertise of UGA Biopharma is the contract development of biologics and biosimilars. This involves all the necessary steps from cell line development and bioprocess development to the development of purification processes and analytics. Furthermore, First CHOice® high-performance cell culture media and feeds are supplied in order to optimize the quality and product concentration of biologics and biosimilars. In addition, UGA Biopharma offers to customers ready-to-use biosimilar cell lines. The company supplies its customers in Germany and abroad from its headquarters in Hennigsdorf (near Berlin) and already has several clients with UGA products in clinical trials or who have already received a marketing authorization. Link: http://www.ugabiopharma.com Summary Products / Services / Technologies: Contract cell line development for biologics for example therapeutic antibodies, bispecific antibodies, fusion proteins, enzymes and hormones.